Rachel M. Jansen

Rachel M. Jansen

Auto-generated profile, based on publicly available information

Rachel M. Jansen

Department of Molecular and Cell Biology University of California Berkeley CA USA

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 October 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
ECEugenia M. Clerico
Eugenia M. Clerico
APAlexandra K. Pozhidaeva
Alexandra K. Pozhidaeva
RJRachel M. Jansen
Rachel M. Jansen
CÖCan Özden
Can Özden
JTJoseph M. Tilitsky
Joseph M. Tilitsky
LGLila M. Gierasch
Lila M. Gierasch
Significance: The cellular functions of Hsp70 molecular chaperones rely on their ability to bind many clients and discriminate folded from unfolded substrates. We find that the Escherichia coli Hsp70 substrate binding domain (SBD) “reads” sequence motifs without regard for backbone orientation and selects binding modes that optimize residue compatibility with pockets in the SBD binding cleft. Multiple potential binding sites on the unfolded substrate interacted with the SBD independently in roughly the same order of apparent affinities observed for the peptide models of the sites. Our results show in detail how an Hsp70 chaperone binds to an unfolded protein substrate, which will inform efforts to predict Hsp70 binding sites and shed light on chaperone functions.

16 September 2022 in Science Advances
Verified
Journal Article
Open access
RJRachel M. Jansen
Rachel M. Jansen
RPRoberta Peruzzo
Roberta Peruzzo
SFSimon A. Fromm
Simon A. Fromm
AYAdam L. Yokom
Adam L. Yokom
RZRoberto Zoncu
Roberto Zoncu
JHJames H. Hurley
James H. Hurley
The mechanistic target of rapamycin complex 1 (mTORC1) regulates cell growth and catabolism in response to nutrients through phosphorylation of key substrates. The tumor suppressor folliculin (FLCN) is a RagC/D guanosine triphosphatase (GTPase)–activating protein (GAP) that regulates mTORC1 phosphorylation of MiT-TFE transcription factors, controlling lysosome biogenesis and autophagy. We determined the cryo–electron microscopy structure of the active FLCN complex (AFC) containing FLCN, FNIP2, the N-terminal tail of SLC38A9, the RagA GDP :RagC GDP.BeFx- GTPase dimer, and the Ragulator scaffold. Relative to the inactive lysosomal FLCN complex structure, FLCN reorients by 90°, breaks contact with RagA, and makes previously unseen contacts with RagC that position its Arg 164 finger for catalysis. Disruption of the AFC-specific interfaces of FLCN and FNIP2 with RagC eliminated GAP activity and led to nuclear retention of TFE3, with no effect on mTORC1 substrates S6K or 4E-BP1. The structure provides a basis for regulation of an mTORC1 substrate-specific pathway and a roadmap to discover MiT-TFE family selective mTORC1 antagonists.

22 November 2022 in FEBS Letters
Verified
Journal Article
Closed access
RJRachel M. Jansen
Rachel M. Jansen
JHJames H. Hurley
James H. Hurley

29 June 2022 in bioRxiv
Verified
Preprint
Open access
PDF file
RJRachel M. Jansen
Rachel M. Jansen
RPRoberta Peruzzo
Roberta Peruzzo
SFSimon A. Fromm
Simon A. Fromm
AYAdam L. Yokom
Adam L. Yokom
RZRoberto Zoncu
Roberto Zoncu
JHJames H. Hurley
James H. Hurley
MTORC1 regulates cell growth and catabolism in response to fluctuations in nutrients through phosphorylation of key substrates. The tumor suppressor FLCN is a RagC GTPase activating protein (GAP) that regulates mTORC1 phosphorylation of TFEB, controlling lysosome biogenesis and autophagy. Here, we determined the cryo-EM structure of the active FLCN complex (AFC) containing FLCN, FNIP2, the N-terminal tail of SLC38A9, the RagA GDP :RagC GDP.BeFx- GTPase dimer, and the Ragulator scaffold. Relative to the inactive lysosomal FLCN complex (LFC) structure, FLCN reorients by 90°, breaks its contacts with RagA, and makes new contacts with RagC that position its Arg164 finger for catalysis. Disruption of the AFC-specific interfaces of FLCN and FNIP2 with RagC eliminated GAP activity in vitro and led to nuclear retention of TFE3, with no effect on mTORC1 phosphorylation of S6K or 4E-BP1. The structure thus provides a roadmap to discover TFEB-selective mTORC1 antagonists. One-Sentence Summary: The cryo-EM structure of the active FLCN RagC GAP complex provides a structural basis for TFEB/TFE3 substrate-selective targeting of mTORC1.